ZO-1 (Tjp1) (C-Terminus) Monoclonal Antibody (F11 Clone) - FFPE Validated

About the Target

When you need to assess ZO-1 C-Terminus (Tjp1) with attention to cellular organization, this antibody provides a focused option. ZO-1 C-Terminus is a structural regulator of intercellular boundaries and tissue architecture. Its behavior can reflect changes in differentiation state, stress, or remodeling of cellular architecture.

In some datasets and protocols, it is referenced by the gene symbol Tjp1.

Research Context

Shifts in junction organization can accompany migration, tissue morphogenesis, and altered mechanical tension. Because regulation can be multi-layered, combining abundance and localization information can sharpen conclusions.

Consider these angles when interpreting target-level changes:

• co-localization patterns with cytoskeletal elements
• changes in complex assembly with scaffold or adaptor proteins
• subcellular redistribution at contact sites versus cytoplasm

Variant Considerations

For paraffin-embedded samples, fixation history and retrieval strategy matter; this option is aligned to those constraints. This matters because epitope exposure and background can vary with preparation and extraction steps. If you compare conditions, keep processing steps uniform to support clean interpretation.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so ZO-1 C-Terminus patterns can be compared across experiments without guesswork.

If your study spans multiple model systems, it can help to define a shared reference condition for ZO-1 C-Terminus so cross-sample contrasts stay meaningful.

As you refine hypotheses around ZO-1 C-Terminus (Tjp1), the fixed-section format helps keep conclusions tied to preparation context.